photo of Dr Paxton Loke

Dr Paxton Loke

Dr Paxton Loke

Details

Role Research Clinician
Dr Paxton Loke is a Research Clinician in the Allergy Immunology group at the Murdoch Children's Research Institute, Consultant Paediatric Allergist Immunologist at Monash Children’s Hospital and MACCS Medical Group and Honorary Fellow at the University of Melbourne. His main research interest is in food oral immunotherapy where he is the Principal Investigator on the multi-centre Probiotic and Peanut Oral Immunotherapy clinical trial and its follow-on study that aims to induce long lasting clinical remission to peanut in children, and an Investigator on probiotic egg and cow’s milk OIT clinical trials.
Dr Paxton Loke is a Research Clinician in the Allergy Immunology group at the Murdoch Children's Research Institute, Consultant Paediatric Allergist Immunologist at Monash Children’s Hospital and MACCS Medical Group and Honorary Fellow at the...
Dr Paxton Loke is a Research Clinician in the Allergy Immunology group at the Murdoch Children's Research Institute, Consultant Paediatric Allergist Immunologist at Monash Children’s Hospital and MACCS Medical Group and Honorary Fellow at the University of Melbourne. His main research interest is in food oral immunotherapy where he is the Principal Investigator on the multi-centre Probiotic and Peanut Oral Immunotherapy clinical trial and its follow-on study that aims to induce long lasting clinical remission to peanut in children, and an Investigator on probiotic egg and cow’s milk OIT clinical trials.

Top Publications

  • Loke, P, Hsiao, K-C, Lozinsky, A, Ashley, S, Lloyd, M, Pitkin, S, Axelrad, C, Jayawardana, K, Tey, D, Su, E-L, et al. Probiotic and Peanut OIT leads to long-lasting sustained unresponsiveness and quality-of-life improvement in peanut-allergic children. 2026
    view publication
  • William, VM, Koplin, J, Allen, K, Robinson, M, smart, J, Loke, P, Peters, R, Dang, T, Lee, K, Dalziel, K, et al. TreEAT Trial: protocol for a randomised controlled trial investigating the efficacy and safety of early introduction of tree nuts for the prevention of tree nut allergy in infants with peanut allergy.. 2026
    view publication
  • Wang, X, Orsini, F, Tang, M, Loke, P. PPOIT-003LT_SAP_analysis_F2toF5_20052025_signed.pdf. 2026
    view publication
  • Lloyd, M, Ashley, S, Chawla, SS, Loke, P, Orsini, F, Lozinsky, AC, Tang, P, Tang, MLK. Impact of Participant Baseline Factors on Exposure-Adjusted Incidence of Treatment-Related Adverse Events During Peanut Oral Immunotherapy.. J Allergy Clin Immunol Pract 13(12) : 3355 -3363.e3 2025
    view publication
  • Brettig, TW, Young, A, Bhatia, R, Bosi, I, Cheung, A, Czech, H, Ford, LS, Katelaris, CH, Lloyd, M, Loke, P, et al. Developing a Standardised National Model of Care for Treatment of Peanut Allergy in Infants: The ADAPT Peanut Oral Immunotherapy Program.. Clin Exp Allergy 2025
    view publication

Page 1 of 14